NCT03720704View on ClinicalTrials.gov

Post-Market Registry of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Implanted in Peripheral Vessels

Active, not recruitingOBSERVATIONAL
Enrollment

280

Participants

Timeline

Start Date

December 18, 2018

Primary Completion Date

April 13, 2022

Study Completion Date

July 31, 2027

Conditions
Peripheral Vascular Diseases
Interventions
DEVICE

GORE VIABAHN VBX Balloon Expandable Endoprosthesis

GORE VIABAHN VBX Balloon Expandable Endoprosthesis will be implanted in peripheral vessels in patients who require interventional treatment.

Trial Locations (11)

Unknown

Hôpital Marie Lannelongue, Paris

University Hospital Heidelberg, Heidelberg

St. Franziskus Hospital, Münster

Azienda Ospedaliera Policlinico Sant'Orsola Malpighi, Bologna

Fondazione Poliambulanza, Brescia

Azienda Ospedaliero-Universitaria di Padova, Padua

Ospedale di Circolo e Fondazione Macchi, Varese

University Medical Center Groningen, Groningen

Erasmus Medical Center, Rotterdam

Hospital Universitario Central de Asturias (HUCA), Oviedo

University Hospital of Santiago de Compostela, Santiago de Compostela

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY

NCT03720704 - Post-Market Registry of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Implanted in Peripheral Vessels | Biotech Hunter | Biotech Hunter